2015
DOI: 10.2217/epi.14.69
|View full text |Cite
|
Sign up to set email alerts
|

Histone Deacetylase 6 in Health and Disease

Abstract: Histone deacetylase (HDAC)6 is a member of the class IIb HDAC family. This enzyme is zinc-dependent and mainly localized in the cytoplasm. HDAC6 is a unique isoenzyme with two functional catalytic domains and specific physiological roles. Indeed, HDAC6 deacetylates various substrates including α-tubulin and HSP90α, and is involved in protein trafficking and degradation, cell shape and migration. Consequently, deregulation of HDAC6 activity was associated to a variety of diseases including cancer, neurodegenera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
196
1
4

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 185 publications
(218 citation statements)
references
References 118 publications
(139 reference statements)
2
196
1
4
Order By: Relevance
“…HDAC6 is the major α-tubulin deacetylase, and its expression is abnormally high in patients with neurodegenerative diseases, including Parkinson’s, amyotrophic lateral sclerosis, and Alzheimer’s, and with cancer and pathological autoimmune responses [78]. In each of our models of IKAP deficiency, we observed increased HDAC6 levels relative to controls (Fig 4A–4D).…”
Section: Resultsmentioning
confidence: 80%
“…HDAC6 is the major α-tubulin deacetylase, and its expression is abnormally high in patients with neurodegenerative diseases, including Parkinson’s, amyotrophic lateral sclerosis, and Alzheimer’s, and with cancer and pathological autoimmune responses [78]. In each of our models of IKAP deficiency, we observed increased HDAC6 levels relative to controls (Fig 4A–4D).…”
Section: Resultsmentioning
confidence: 80%
“…HDAC6-selective inhibitors are currently under investigation in multiple clinical settings, including cancer and neurodegenerative diseases 11, 32-34. Our findings suggest that the side effects of HDAC6 inhibition on immunity should be considered as a part of clinical trials.…”
Section: Discussionmentioning
confidence: 83%
“…The abundant expression level of acetylated a-tubulin was also demonstrated in walleye brain and retina extracts. In vertebrates, the addition of acetyl to tubulin is done mainly by a-tubulin acetyltransferase 1 (aTAT1 or also known as mechanosensory protein 17 or MEC-17) (Akella et al 2010), whereas removal is done with a histone deacetylase, HDAC6 (Seidel et al 2015), and/or a sirtuin family member, SIRT2 (Skoge et al 2014). For fish, MEC-17, HDAC6 and SIRT2 have been studied almost exclusively in zebrafish (Akella et al 2010;Kaluza et al 2011;Zhou et al 2014), but these cell lines should allow acetylation/ …”
Section: Discussionmentioning
confidence: 99%